Join
Live feed
·
INSIDERFilingvia Quantisnow
BioCryst Pharmaceuticals Inc. logo

Director Stonehouse Jon P was granted 421 shares, exercised 305,995 shares at a strike of $3.22 and returned $2,643,797 worth of shares to the company (305,995 units at $8.64), increasing direct ownership by 0.03% to 1,323,850 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.